Drug Trial Radar · NCT03418480
HARE-40: HPV Anti-CD40 RNA vaccinE
Last checked: Nov 19, 2026Latest source record: Oct 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
30
Actual
Start
Apr 11, 2017
Primary completion
Nov 1, 2023
Study completion Jan 24, 2024
Sponsor
- Lead sponsor
- University of SouthamptonAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- BioNTech SE
- First posted
- Feb 1, 2018
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
HARE-40 is a phase I/II vaccine dose escalation study with two different arms: Arm 1A will perform intrapatient dose escalation in patients with previously treated HPV16+ Head \& Neck Cancer using two dose cohorts to establish a safe, tolerable and recommended dose of HPV vaccine. Arm 1B will perform intrapatient dose escalation in patients with advanced HPV16+ cancer (head and neck, anogenital, penile, cervical and other) using a single cohort to establish a safe, tolerable and recommended dose of HPV vaccine.
Conditions
- Human Papilloma Virus Related Carcinoma
- Head and Neck Neoplasm
- Cervical Neoplasm
- Penile Neoplasms Malignant
- Unknown Primary Tumors
Interventions
BNT113Drug
Intravenous vaccine
Primary outcomes
What the sponsor says the trial is designed to measure.
- Dose Limiting Toxicity (DLT) according to CTCAE version 4.03 (Arm 1A and Arm 1B)Time frame: Adverse Events reported from the time of first vaccine administration up to 28 days after the last administration. Serious Adverse Events suspected to be related to study drug to be reported until the end of follow up.
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
The Christie NHS Foundation Trust
Manchester, United Kingdom
Univeristy Hospitals Southampton NHS Foundation Trust
Southampton, Hampshire, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.